US Stock MarketDetailed Quotes

IPHA Innate Pharma

Watchlist
  • 1.820
  • -0.055-2.93%
Trading Nov 4 15:35 ET
147.33MMarket Cap-4000P/E (TTM)

Innate Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Innate Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 10, 20202019/Q413.330M / 22.402M--
--2019/Q313.330M / 24.747M--
Sep 13, 20192019/Q229.580M / 43.206M--
--2019/Q1-- / 43.206M--
DatePeriodRevenue/EstimateEarnings Call
Mar 10, 20202019/Q413.330M / 22.402M--
--2019/Q313.330M / 24.747M--
Sep 13, 20192019/Q229.580M / 43.206M--
--2019/Q1-- / 43.206M--
--------

Unlock Free Earnings Estimates

Innate Pharma Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 12 06:19 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 12 06:09 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    May 14 06:10 ET

  • Innate Pharma | 20-F: FY2023 Annual Report

    Apr 4 08:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data